DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 02 · Volume 55 · 1986 DOI: 10.1055/s-009-45128

Original Article

153
Connellan, J M; Thurlow, P J; Barlow, Bernadette; Lowe, Melinda; McKenzie, I F C: Investigation of Alternative Mechanisms of Collagen - Induced Platelet Activation by Using Monoclonal Antibodies to Glycoprotein IIb-IIIa and Fibrinogen
158
Taylor, L D; Dean, F L; Tiedemann, K; Ekert, H: An Inhibitor to Factor VIII: C in a Patient with Possible Combined Haemophilia A and von Willebrand’s Disease
162
Yamamoto, K; Yamamoto, N; Kitagawa, H; Tanoue, K; Kosaki, G; Yamazki, H: Localization of a Thrombin-Binding Site on Human Platelet Membrane Glycoprotein Ib Determined by a Monoclonal Antibody
168
Blache, D; Nargeot, J; Nerbonne, J M: Direct Evidence for the Inhibition of Platelet Aggregation and Release by Intracellular Cyclic AMP Produced with a New Photoactivatable Derivative
173
Desai, K; Owen, J S; Wilson, D T; Hutton, R A: Platelet Aggregation and Plasma Lipoproteins in Alcoholics During Alcohol Withdrawal
178
Shimada, N; Tsubokura, M; Kimura, N: Isolation and Partial Characterization of Adenylate Cyclase-Enriched Membranes from Human Platelets
184
Feuerstein, I A; Kush, J: Platelet Adherence and Detachment - In What Ways Is Surface-Bound Albumin Different from Surface-Bound Fibrinogen?
189
Wiman, B; Rånby, M: Determination of Soluble Fibrin in Plasma by a Rapid and Quantitative Spectrophotometric Assay
194
Kaiser, B; Markwardt, F: Experimental Studies on the Antithrombotic Action of a Highly Effective Synthetic Thrombin Inhibitor
197
Jacobs, R M; Murtaugh, R J; Fertel, R H: Platelet Function in Experimentally Induced Pancreatitis in the Dog
201
Kruithof, E K O; Tran-Thang, C; Bachmann, F: Studies on the Release of a Plasminogen Activator Inhibitor by Human Platelets
206
Nielsen, L S; Andreasen, P A; Grøndahi-Hansen, J; Huang, J Y; Kristensen, P; Danø, K: Monoclonal Antibodies to Human 54,000 Molecular Weight Plasminogen Activator Inhibitor from Fibrosarcoma Cells - Inhibitor Neutralization and One-Step Affinity Purification
213
Philips, M; Juul, Anne-Grethe; Thorsen, S; Selmer, J; Zeuthen, J: Immunological Relationship Between the Fast-Acting Plasminogen Activator Inhibitors from Plasma, Blood Platelets and Endothelial Cells Demonstrated with a Monoclonal Antibody Against an Inhibitor from Placenta
218
Fischer, A M; Cornu, P; Sternberg, C; Mériane, F; Dautzenberg, M D; Chafa, O; Beguin, S; Desnos, M: Antithrombin III Alger: A New Homozygous AT III Variant
222
Brandon, Roslyn A; Emmett, J A G; Eadie, M J; Curran, A C W; Bunce, I H: Peripheral Venous Plasma Aspirin Concentrations and Platelet Aggregation Inhibition Produced by Enteric-Coated Aspirin Formulations
228
Zucker, Marjorie B; Mauss, Evelyn A: Modification of Platelet Functions by Monobromobimane, a Fluorescent Thiol Group Label
235
Wallin, R; Susan, D; Patrick, D; Ballard, J O: Vitamin K Antagonism of Coumarin Intoxication in the Rat
240
Rybak, M E: Glycoproteins IIb and IIIa and Platelet Thrombospondin in a Liposome Model of Platelet Aggregation
246
Lombardi, Rossana; Gelfi, Cecilia; Righetti, P G; Lattuada, Antonella; Mannucci, P M: Electroblot and Immunoperoxidase Staining for Rapid Screening of the Abnormalities of the Multimeric Structure of von Willebrand Factor in von Willebrand’s Disease
250
Stevenson, K J; Easton, Ann C; Curry, A; Thomson, Jean M; Poller, L: The Reliability of Activated Partial Thromboplastin Time Methods and the Relationship to Lipid Composition and Ultrastructure
259
Earnshaw, J J; Westby, J C; Makin, G S; Hopkinson, B R: The Systemic Fibrinolytic Effect of BRL 26921 During the Treatment of Acute Peripheral Arterial Occlusions
263
Aihara, M; Sawada, Y; Ueno, K; Morimoto, S; Yoshida, Y; Serres, M de; Copper, H A; Wegner, R H: Visualization of von Willebrand Factor Multimers by Immunoenzymatic Stain Using Avidin-Biotin Peroxidase Complex
268
Alexander, R J: Immunological Evidence for Prothrombin in Human Platelets
271
Ireland, Helen; Lane, D A; Flynn, Angela; Anastassiades, E; Curtis, J R: The Anticoagulant Effect of Heparinoid Org 10172 During Haemodialysis: An Objective Assessment
276
Brosstad, F; Kjønniksen, Inge; Rønning, B; Stormorken, H: Visualization of von Willebrand Factor Multimers by Enzyme-Conjugated Secondary Antibodies
279
Marshall, J M; Rees, M C P; Cederholm-Williams, S A: Identification of t-PA as the Major Active Plasminogen Activator in Human Milk

International Committee Communications

282
Boissel, J P: ICTH - Subcommittee on Clinical Trials: Registry of Multicenter Clinical Trials

Letter to the Editor

292
Llopis, F; González-Molina, A; Aznar, J A; Jorquera, J I; Carmona, E; Villanueva, M J; Trenor, A; Sánchez-Cuenca, J M: Auto-Antibodies in Haemophilia A and B
293
Triantaphyllopoulos, D C; Cho, M S: Effect of Injection of C1 Inactivator on the Platelet Count and Blood Coagulation in Rabbits Infused with Endotoxin
294
Vitoux, J.-F; Roncato, M; Hourdebaigt, P; Aiach, M; Fiessinger, J.-N: Heparin-Induced Thrombocytopenia and Pentosan Polysulfate: Treatment with a Low Molecular Weight Heparin Despite In Vitro Platelet Aggregation
296
Cordova, C; Violi, F; Ghiselli, A; Alessandri, C; Frattaroli, S: In Vitro Effect of Vitamin E and Butylated Hydroxytoluene on Plasma ’ Malondialdehyde-Like Material Formation
297
Kariya, K; Aihara, K; Ueno, A; Kimura, A; Yoshida, Y: Von Willebrand Factor and Major Blood Groups in Japan
298
Bounameaux, H; Lijnen, H R; Hellemans, M; Verstraete, M: Effect of Standard and Low-Molecular Weight Heparin Fractions on Fibrinolysis and Platelet Aggregation in Patients Undergoing Hysterectomy
299
Richard, C; Sedano, C; Cuadrado, M A; Iriondo, A; Bello, C; Gandarillas, M A; Zubizarreta, A: Effect of a Thymic Factor on the Concentration of a Factor VIII Inhibitor in a Patient with Treated Hodgkin’s Disease
301
Henny, Ch P; Cate, H ten; Cate, J W ten; Prummel, M F; Peters, M; Büller, H R: Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid
302
Cruickshank, Dr. Alexander M: Gordon Research Conference on Hemostasis